In my opinion, Mounjaro stands more of a chance of being approved on State schemes as it achieves greater weight loss and slightly better blood sugar control
The majority of people who take these drugs experience nausea at some point some have it more severe than others, Amber L
Both promise the same active ingredient found in brand-name Mounjaro and Zepbound, but with added compounds designed to reduce side effects and improve the overall experience
I think that once Mounjaro is approved for weight loss at the end of 2023 this trend will gain steam in a significant way, which would likely reflect in Q2-Q3 2024 earnings for PHG, RMD etc
That does not make every patient eligible, guarantee weight loss, or make compounded medication FDA approved
[PubMed] [Google Scholar] 103.Won H.R., Lee G.H., Kim J.H., Lee S.H., Kwon S.Y., Baek S.K., Ryu C.H., Lee S.J., Park I.S., Shin S.C., et al